. . . . . . . . . "yondelis r see clinical studies 14 yondelis is an alkylating drug indicated for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline containing regimen 1" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "OpRNwmobRrtAlulYhwwTz6zqdg+2aWH2RVF53W2MXR5t0dYCXu3IWYYQ+YDj1VIYiR5kdPJeWyc1VbwINY779RQ3OZ4Gyy+ZUTRBnYGS+7VhpYxxVyNOlr1urNOVeqeAC6hEFS4hoGdO1SFoE4Gl/u6HV6Ukv4qk/DXwEaRDoLM=" . . "2021-07-03T15:44:45.835+02:00"^^ . . . . .